Novel Molecular Insights into Human Lipid-Mediated T Cell Immunity.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Mar 2021
Historique:
received: 05 02 2021
revised: 02 03 2021
accepted: 03 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 23 4 2021
Statut: epublish

Résumé

T cells represent a critical arm of our immune defense against pathogens. Over the past two decades, considerable inroads have been made in understanding the fundamental principles underpinning the molecular presentation of peptide-based antigens by the Major Histocompatibility Complex molecules (MHC-I and II), and their molecular recognition by specialized subsets of T cells. However, some T cells can recognize lipid-based antigens presented by MHC-I-like molecules that belong to the Cluster of Differentiation 1 (CD1) family. Here, we will review the advances that have been made in the last five years to understand the molecular mechanisms orchestrating the presentation of novel endogenous and exogenous lipid-based antigens by the CD1 glycoproteins and their recognition by specific populations of CD1-reactive T cells.

Identifiants

pubmed: 33807663
pii: ijms22052617
doi: 10.3390/ijms22052617
pmc: PMC7961386
pii:
doi:

Substances chimiques

Antigens 0
Antigens, CD1 0
Histocompatibility Antigens Class I 0
Lipids 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Australian Research Council
ID : FT160100074
Organisme : Australian Research Council
ID : DE210101031

Références

Sci Immunol. 2017 Dec 22;2(18):
pubmed: 29273672
Curr Opin Immunol. 2018 Jun;52:93-99
pubmed: 29738961
Science. 2019 Dec 20;366(6472):1522-1527
pubmed: 31857486
Prog Lipid Res. 2013 Oct;52(4):590-614
pubmed: 24007978
Immunity. 2013 Dec 12;39(6):1032-42
pubmed: 24239091
Nat Rev Immunol. 2004 Mar;4(3):231-7
pubmed: 15039760
J Immunol. 2011 Jul 1;187(1):309-15
pubmed: 21632718
J Immunol. 2006 Mar 15;176(6):3625-34
pubmed: 16517731
J Exp Med. 2013 Apr 8;210(4):729-41
pubmed: 23530121
Nat Immunol. 2014 Feb;15(2):177-85
pubmed: 24362891
Nat Immunol. 2015 Nov;16(11):1114-23
pubmed: 26482978
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):380-5
pubmed: 26621732
J Immunol. 2010 Feb 1;184(3):1235-41
pubmed: 20026739
J Immunol. 2004 Feb 15;172(4):2382-8
pubmed: 14764708
PLoS Biol. 2012;10(10):e1001412
pubmed: 23109910
Nat Immunol. 2016 Oct;17(10):1159-66
pubmed: 27548435
Nat Immunol. 2010 Dec;11(12):1102-9
pubmed: 21037579
Annu Rev Immunol. 2015;33:169-200
pubmed: 25493333
Mol Immunol. 2018 Dec;104:27-36
pubmed: 30399491
J Immunol. 2002 Jun 1;168(11):5514-20
pubmed: 12023346
J Immunol. 2014 May 1;192(9):4054-60
pubmed: 24683194
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33393500
Nat Immunol. 2012 Sep;13(9):857-63
pubmed: 22820603
Annu Rev Immunol. 2004;22:817-90
pubmed: 15032598
Sci Transl Med. 2016 Feb 10;8(325):325ra18
pubmed: 26865566
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1266-75
pubmed: 26884207
Nat Rev Immunol. 2012 Dec;12(12):845-57
pubmed: 23154222
Eur J Immunol. 2017 Jul;47(7):1171-1180
pubmed: 28440548
J Exp Med. 2016 Oct 17;213(11):2399-2412
pubmed: 27670592
Sci Rep. 2015 Jun 30;5:11737
pubmed: 26122953
Nat Immunol. 2013 Nov;14(11):1137-45
pubmed: 24076636
Nat Commun. 2019 Jan 4;10(1):56
pubmed: 30610190
J Exp Med. 2015 Feb 9;212(2):149-63
pubmed: 25584012
J Immunol. 2018 Jan 15;200(2):500-511
pubmed: 29237773
Oncoimmunology. 2016 Jul 22;5(9):e1213932
pubmed: 27757307
Nature. 2000 Apr 20;404(6780):884-8
pubmed: 10786796
Nat Immunol. 2003 Aug;4(8):808-15
pubmed: 12833155
Science. 1997 Oct 10;278(5336):283-6
pubmed: 9323206
Sci Immunol. 2020 Jan 3;5(43):
pubmed: 31901073
Nat Immunol. 2012 Sep;13(9):851-6
pubmed: 22820602
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22944-22952
pubmed: 32868441
Eur J Immunol. 2011 Mar;41(3):602-10
pubmed: 21246542
Sci Immunol. 2017 Oct 20;2(16):
pubmed: 29054999
Immunity. 2005 Feb;22(2):209-19
pubmed: 15723809
Nat Commun. 2016 Feb 15;7:10570
pubmed: 26875526
J Immunol. 2019 Dec 15;203(12):3395-3406
pubmed: 31694911
J Clin Invest. 2017 Jun 1;127(6):2339-2352
pubmed: 28463230
Nat Rev Immunol. 2005 May;5(5):387-99
pubmed: 15864273
Immunity. 2010 Dec 14;33(6):853-62
pubmed: 21167756
J Immunol. 2016 Feb 15;196(4):1933-42
pubmed: 26755823
EMBO J. 2006 Aug 9;25(15):3684-92
pubmed: 16874306
Nat Immunol. 2013 Jul;14(7):706-13
pubmed: 23727893
J Exp Med. 1994 Sep 1;180(3):1097-106
pubmed: 7520467
Eur J Immunol. 2016 Jan;46(1):242-52
pubmed: 26518614
Nat Immunol. 2018 Apr;19(4):397-406
pubmed: 29531339
Nat Commun. 2016 Oct 27;7:13257
pubmed: 27807341
Adv Exp Med Biol. 2007;598:20-34
pubmed: 17892202
J Exp Med. 2014 Dec 15;211(13):2599-615
pubmed: 25452463
Eur J Immunol. 2012 Sep;42(9):2505-10
pubmed: 22829134
Nat Immunol. 2015 Mar;16(3):258-66
pubmed: 25642819
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):E4648-57
pubmed: 25298532

Auteurs

Adam Shahine (A)

Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia.

Marcin Wegrecki (M)

Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.

Jérôme Le Nours (J)

Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH